Frontlight ResearchEarly access
Neuroendocrine tumours trials in United States
89 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleDESTINY-PANTUMOUR04
- Where
- Birmingham, Boulder, Bullhead City, Canton, Casa Grande, Coral Springs, Dallas, Decatur, Durham, Farmington, Maumee, Nashville, Philadelphia, San Diego, St. Petersburg, Topeka, West Palm Beach, Wilson
- Age
- 18 years to 130 years
- People
- 100
- Run by
- AstraZeneca
See details and how to joinNCT07124000 - Phase 1Taking peoplePhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
- Where
- Boston, Iowa City, Royal Oak, Seattle
- Age
- 18 years to 100 years
- People
- 116 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07006727 · EU 2024-519111-34-00 - No phaseTaking peopleEQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Where
- Cleveland
- Age
- 18 years and over
- People
- 200
- Run by
- Case Comprehensive Cancer Center
See details and how to joinNCT06263088 - No phaseTaking peopleEstablishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix
- Where
- Houston
- People
- 750
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04723095 - Phase 3Taking peopleStudy to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
- Where
- Atlanta, Austin, Dallas, Denver, Detroit, Edgewood, Fairfax, Fayetteville, Hartford, Jacksonville, Nashville, New Haven, New Orleans, New York, Norfolk, Orlando, Scottsdale, Tacoma, Wytheville
- Age
- 12 years to 100 years
- People
- 240 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06784752 · EU 2024-518325-15-00 - No phaseTaking peopleProject: Every Child for Younger Patients With Cancer
- Where
- Akron, Albany, Albuquerque, Allentown, Amarillo, Anchorage, Ann Arbor, Asheville, Atlanta, Augusta, Aurora, Austin, Baltimore, Bangor, Battle Creek, Bethesda, Bethlehem, Birmingham, Boise, Boston, Brooklyn, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chattanooga, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Denver, Des Moines, Detroit, Downey, Duarte, Durham, East Lansing, Effingham, El Paso, Falls Church, Fargo, Flint, Fort Lauderdale, Fort Myers, Fort Sam Houston, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Henderson, Hershey, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Kingman, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Loxahatchee Groves, Lubbock, Macon, Madera, Madison, Marshfield, Mattoon, Maywood, McAllen, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Muskegon, Nashville, Neptune City, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Niles, Norfolk, Normal, Norton Shores, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Pahrump, Palo Alto, Park Ridge, Paterson, Pensacola, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Reed City, Reno, Richmond, Roanoke, Rochester, Royal Oak, Sacramento, Saint Joseph, Salt Lake City, San Antonio, San Diego, San Francisco, Santa Barbara, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, Stony Brook, St. Petersburg, Syracuse, Tacoma, Tampa, Temple, The Bronx, Toledo, Torrance, Traverse City, Tucson, Tulsa, Urbana, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winfield, Winston-Salem, Worcester, Wyoming, Yorkville
- Age
- Up to 25 years
- People
- 75,000 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT02402244 - Phase 2Taking peopleThe Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue)
- Where
- Salt Lake City
- Age
- 18 years and over
- People
- 86
- Run by
- University of Utah
See details and how to joinNCT07151391 - Early phase 1Taking peopleAn Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer
- Where
- Ann Arbor
- Age
- 18 years and over
- People
- 30
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT07132645 - Phase 2Taking peopleTrial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 111
- Run by
- Fox Chase Cancer Center
See details and how to joinNCT05263050 - Phase 2Taking peopleDAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Where
- Baltimore, Boston, Indianapolis, Jacksonville, Lexington, Los Angeles, Miami, Mobile, New York, Phoenix, Richmond, Rochester, San Francisco, Tampa, The Bronx, Westwood
- Age
- 18 years and over
- People
- 204 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00 - No phaseTaking peopleAssociation Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- Where
- Houston
- Age
- 18 years and over
- People
- 590
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT01365169 - Phase 1/2Taking peopleA Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
- Where
- Baltimore, Boston, Chapel Hill, Denver, Duarte, Durham, Fairfax, Los Angeles, New Haven, Oklahoma City, Portland, San Antonio, Seattle, St Louis
- Age
- 18 years and over
- People
- 203
- Run by
- Phanes Therapeutics
See details and how to joinNCT05652686 - Phase 1/2Taking peopleAtezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
- Where
- Gainesville
- Age
- 18 years to 99 years
- People
- 29
- Run by
- University of Florida
See details and how to joinNCT05000294 - Phase 1/2Taking peopleA Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- Where
- Denver, Fairfax, Fort Wayne, Grand Rapids, Houston, Irving, Nashville, New York, Orlando, Philadelphia, Seattle
- Age
- 18 years and over
- People
- 262 worldwide
- Run by
- IDEAYA Biosciences
See details and how to joinNCT07174583 · EU 2025-523438-24-00 - No phaseTaking peopleIntegrated Cancer Repository for Cancer Research
- Where
- Aitkin, Alliance, Aurora, Bozeman, Brainerd, Canton, Council Bluffs, Daytona Beach, DeLand, Duluth, Fargo, Fayetteville, Fergus Falls, Fort Wayne, Glens Falls, Green Bay, Greenwood Village, Hastings, Holyoke, Kansas City, Liberty, Manchester, Minot, Norfolk, North Kansas City, North Platte, Omaha, Orange City, Overland Park, Palm Coast, Randallstown, Saint Joseph, Tallahassee, Utica, Waterloo, Westminster, Yorkville
- Age
- 19 years to 110 years
- People
- 999,999
- Run by
- University of Nebraska
See details and how to joinNCT02012699 - Phase 2Taking peopleAtezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer
- Where
- Baltimore, Washington D.C.
- Age
- 18 years and over
- People
- 63
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT05312671 - Phase 4Taking peopleSurgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors
- Where
- Nashville
- Age
- 18 years and over
- People
- 6
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT06016855 - Phase 2Not yet taking people in United StatesAUR103 Calcium in Advanced Neuroendocrine Tumours (BHARAT-3 Study)
- Where
- Jacksonville, Newport Beach, Philadelphia, Phoenix, Rochester
- Age
- 18 years to 99 years
- People
- 30
- Run by
- Aurigene Discovery Technologies Limited
See details and how to joinNCT07640737 - No phaseTaking peopleBreathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
- Where
- Rochester
- Age
- 18 years to 85 years
- People
- 147
- Run by
- Mayo Clinic
See details and how to joinNCT06788886 - Phase 1Taking peopleDose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
- Where
- Fort Worth, Los Angeles, West Valley City
- Age
- 18 years and over
- People
- 40
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT07517198 - No phaseTaking peopleNutrition Intervention for Pancreatic Cancer
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 18
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT07554560 - Phase 1Taking peopleSVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
- Where
- Miami
- Age
- 18 years and over
- People
- 36
- Run by
- Peter Hosein, MD
See details and how to joinNCT06889493 - Phase 1/2Taking peopleDose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
- Where
- Palo Alto, Philadelphia
- Age
- 20 years to 99 years
- People
- 25
- Run by
- Teclison Ltd.
See details and how to joinNCT02174549 - No phaseTaking peoplePeptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
- Where
- Dallas
- Age
- 18 years and over
- People
- 50
- Run by
- Methodist Health System
See details and how to joinNCT04090034 - Phase 1Taking peopleGene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
- Where
- Duarte, Los Angeles, Stanford
- Age
- 18 years to 75 years
- People
- 18
- Run by
- Anusha Kalbasi
See details and how to joinNCT04119024